Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated stereotactic boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas

Tumori

Volumn 95, Issue 3, 2009, Pages 329-337

  Pirtoli, Luigi ^a,d   Rubino, Giovanni ^b,d   Marsili, Stefania ^b,d   Oliveri, Giuseppe ^b,d   Vannini, Marta ^b,d   Tini, Paolo ^a,d   Miracco, Clelia ^a,d   Santoni, Riccardo ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Istituto Tumori Toscano (ITT)   (Italy)

Author keywords

Chemotherapy; High dose boost; High grade glioma; Radiotherapy; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ARTICLE; BRAIN RADIATION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; PALLIATIVE THERAPY; POSTOPERATIVE CARE; STEREOTACTIC TREATMENT; SURVIVAL RATE;

HIGH DOSE; HIGH-GRADE GLIOMAS; MULTI VARIATE ANALYSIS; PALLIATIVE RADIOTHERAPY; RADICAL IRRADIATION; TEMOZOLOMIDE; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY; WHOLE-BRAIN IRRADIATION;

CHEMORADIOTHERAPY; CHEMOTHERAPY; IRRADIATION; RADIOTHERAPY; TUMORS;

THREE DIMENSIONAL;

EID: 67849126537     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500310     Document Type: Article

References (20)

1. Salazar O, Rubin P, Feldstein ML, Pizzutiello R: High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys, 5: 1733-1740, 1979. (Pubitemid 10187519)
2. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant glioma. Int J Radiat Oncol Biol Phys, 5: 1725-1731, 1979.
3. Chang CH, Horton MB, Schoenfeld D, Salazar O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y: Comparison of postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer, 52: 997-1007, 1983.
4. Miller PJ, Hassanein RS, Giri PG, Kimler BF, O'Boynick P, Evans RG: Univariate and multivariate statistical analysis of high-grade gliomas: the relation of radiation dose and other prognostic factors. Int J Radiat Oncol Biol Phys, 19: 275-280, 1990. (Pubitemid 20299018)
5. Furst Nelson D, Curran WJ Jr, Scott C, Nelson JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis W, Mohiuddin M, Fischbach J: Hyperfractionated radiation therapy and bis-chloroethyl nitrosourea in the treatment of malignant glioma - possible advantage observed at 72.0 in 1.2 Gy b.i.d. fractions: report of the Radiation Therapy Oncology Group protocol 8302. Int J Radiat Oncol Biol Phys, 25: 193-207, 1993. (Pubitemid 23048771)
6. Burnet NG, Jena R, Jefferies SJ, Stenning SP, Kirkby NF: Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol, 18: 93-103, 2006. (Pubitemid 43169136)
7. Souhami L, Seiferheld W, Brachman D, Podgorsak E, Werner-Wasik M, Lustig R, Schultz C, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta M, Curran W: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys, 60: 853-860, 2004.
8. Cardinale R, Won M, Choucair A, Gillin M, Chakravarti A, Schultz C, Souhami L, Chen A, Pham H, Mehta M: A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys, 65: 1422-1428, 2006. (Pubitemid 44425201)
9. Mason WP, Del Maestro R, Eisenstat D, Forsyth P, Fulton D, Laperrière N, Macdonald D, Perry J, Thiessen B: Canadian recommendation for the treatment of glioblastoma multiforme. Curr Oncol, 14: 110-117, 2007. (Pubitemid 47204238)
10. Baumert BG, Lutterbach J, Bernays R, Davis JB, Heppner F: Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas. Radiother Oncol, 67: 183-190, 2003. (Pubitemid 36700461)
11. Tanaka M, Ino Y, Nagakawa K, Tago M, Todo T: High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. Lancet Oncol, 6: 953-960, 2005. (Pubitemid 41685228)
12. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn M, Belanger K, Brandes A, Marosi C, Bogdahn U, Curschmann J, Janzer R, Ludwin S, Gorlia T, Allgeier A, Lacombe D, Cairncross G, Eisenhauer E, Mirimanoff R: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352: 987-996, 2005.
13. Fatigante L, Cionini L, Nocita AM, Luppatelli M, Tagliagambe A, Grillo Ruggeri F, Pirtoli L, Paccapelo A: Safety and efficacy of temozolomide concomitant and sequential to radiotherapy in glioblastoma multiforme: results of a phase II multicentric study. Proc ASCO, 22: 424, 2003.
14. Curran WJ Jr, Scott CB, Horton J, Nelson J, Weinstein A, Fischbach J, Chang C, Rotman M, Asbell S, Krisch R, Nelson D: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst, 85: 704-710, 1993.
15. Fiveash JB, Nordal RA, Markert JM, Ahmed R, Nabors LB: High-grade gliomas. In: Clinical radiation oncology, Gunderson LL, Tepper JE (Eds), pp 515-537, Elsevier-Churchill Livingstone, Philadelphia, 2007.
16. Emami B, Lyman J, Brown A, Coia L, Gottein M, Munzenrider J, Shank B, Solin L, Wesson M: Tolerance of normal tissues to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21: 109-122, 1991.
17. Magrini SM, Ricardi U, Santoni R, Krengli M, Luppatelli M, Cafaro I, Scoccianti S, Menichelli C, Bertani F, Maurizi Endici R, Tombolini V, Buglione M, Pirtoli L: Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys, 65: 788-799, 2006.
18. McAleese JJ, Stenning SP, Ashley S, Traish D, Hines F, Sardell S, Guerrero D, Brada M: Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother Oncol, 67: 177-182, 2003. (Pubitemid 36695096)
19. Roa W, Brasher G, Bauman G, Anthes M, Bruera E, Chan A, Fisher B, Fulton D, Gulavita S, Hao C, Husain S, Murtha A, Petruk K, Stewart D, Tai P, Urtasun R, Cairncross JG, Forsyth P: Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol, 22: 1583-1588, 2004. (Pubitemid 41079795)
20. Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibinia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G: Accelerated hypofractionated intensity- modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. Int J Radiat Oncol Biol Phys, 73: 473-478, 2009.